Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 188.88B P/E 33.02 EPS this Y 5.00% Ern Qtrly Grth -5.30%
Income 5.54B Forward P/E 23.51 EPS next Y 10.30% 50D Avg Chg 2.00%
Sales 40.73B PEG 2.97 EPS past 5Y 7.17% 200D Avg Chg 3.00%
Dividend 2.00% Price/Book 5.10 EPS next 5Y 8.20% 52W High Chg -6.00%
Recommedations 2.00 Quick Ratio 1.02 Shares Outstanding 1.74B 52W Low Chg 16.00%
Insider Own 0.53% ROA 6.26% Shares Float 1.73B Beta 0.72
Inst Own 77.49% ROE 14.44% Shares Shorted/Prior 13.36M/12.68M Price 108.62
Gross Margin 55.48% Profit Margin 13.65% Avg. Volume 4,711,008 Target Price 124.53
Oper. Margin 17.66% Earnings Date Oct 16 Volume 4,699,325 Change -1.73%
About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories News
11/16/24 Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now
11/14/24 3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years
11/13/24 US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024
11/13/24 Abbott Laboratories (NYSE:ABT) shareholders have earned a 8.6% CAGR over the last five years
11/09/24 Is Abbott Laboratories' (NYSE:ABT) Recent Stock Performance Influenced By Its Financials In Any Way?
11/08/24 If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?
11/08/24 The Zacks Analyst Blog Highlights like Amazon.com, Procter & Gamble, Abbott and NVE
11/08/24 Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
11/07/24 Top Stock Reports for Amazon.com, Procter & Gamble & Abbott
11/07/24 Abbott Laboratories (ABT) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates Era
11/05/24 Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
11/05/24 Abbott Laboratories Insiders Sell US$3.0m Of Stock, Possibly Signalling Caution
11/05/24 Abbott price target raised to $149 from $143 at Barclays
11/04/24 Is Abbott Laboratories (ABT) the Best Pharma Stock to Buy Right Now?
11/01/24 Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial
11/01/24 Abbott, Reckitt found not liable in baby formula case. Stocks rise.
11/01/24 Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case
11/01/24 Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
11/01/24 Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win
11/01/24 Abbott shares rise after securing first win in premature infant formula trial
ABT Chatroom

User Image Taavi240 Posted - 2 days ago

$ABT holding up well so far..

User Image swingingtech Posted - 2 days ago

$SPXL, $MMM, $ABT, $ACN https://wallstreetwaves.com/significant-outflow-impacting-direxion-daily-sp-500-bull-3x-shares/

User Image Article_AI Posted - 2 days ago

$ABT 3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years These are income stocks you can buy and hold forever. https://www.stck.pro/news/ABT/93120612/

User Image LavaSniper Posted - 3 days ago

💥 Huge news expected for MYNZ soon 💥 Nov 12: 51M volume, +28%, with 19M short volume. With everyone awaiting the meeting results, I have a strong feeling the r/s extension will be pushed out another 180 days. Mainz Biomed (MYNZ) has partnered with Thermo Fisher (TMO, $209.2B market cap, trading at ~$546.92) to develop a next-gen colorectal cancer screening tool for global markets. Thermo Fisher’s $42.4B revenue and advanced tech will boost MYNZ’s mRNA-based assays, achieving 85% detection for advanced adenomas, compared to competitors' 43% and 20%. With CRC cases up 500% in young people, MYNZ is leading early detection. Sentiment: Positive 1. Strategic partnership with industry giant Thermo Fisher 2. Access to Thermo Fisher's advanced tech 3. Potential for global commercialization 4. Development of home collection screening capability Win-win as TMO steps into the CRC market, too. Calling all apes, let’s crush the short sellers—this bull run is ours. $MRVL $ABT

User Image JamesWooster390 Posted - 3 days ago

$ABT When other companies are generating such excitement, it’s tough to justify waiting for KSCP’s next step.

User Image Seanwishwise Posted - 4 days ago

$TTOO in oversold zone. Anticipating a potential rebound. Collaboration with prxcision may help in enhancing diagnostic capabilities. $DGX $LH $TMO $ABT

User Image MakingMeMeoutofME Posted - 4 days ago

$MDT I feel an upgrade or 2 before Friday $ABT $SYK $BSX medical device plays 100 target on CEO's positive comments

User Image MakingMeMeoutofME Posted - 4 days ago

$MDT breakout of 88.88 and we see 90 $SYK $ABT $BSX

User Image MakingMeMeoutofME Posted - 4 days ago

$MDT ready to for 100 for all the $SYK traders to take notice $ABT $BSX traders inverse head and shoulders formed

User Image MakingMeMeoutofME Posted - 4 days ago

$MDT still calling for an upgrade pre eps 11/19 pre mkt $BSX $ABT $SYK 2H revs EPS growth being called by CEO

User Image TickerDD_com Posted - 4 days ago

$ABT How much is ABT Shorted? What is Short Interest for ABT? As of 10-31-2024 https://youtu.be/EHiuGFeJAtY

User Image UndiscoveredbUlls Posted - 4 days ago

💥 Boom 🚨 Big news! LFGOOOOOO! Mainz Biomed MYNZ has teamed up with Thermo Fisher TMO (mkt cap $209.2B, trading at ~$546.92) to develop a next-gen colorectal cancer screening tool for global markets. Thermo Fisher’s $42.4B annual revenue and advanced tech will boost MYNZ’s mRNA-based assays, hitting 85% detection for advanced adenomas vs. competitors’ 43% and 20%. With CRC cases up 500% in young people, MYNZ is leading early detection. Win-win for both sides — TMO stepping into the CRC market too. Big developments ahead! Calling all apes, let's crush these shorties—this time is bull time. Insane news, we've been waiting for!!! $PG $ABT

User Image ncbc77 Posted - 5 days ago

@WildKevin my point exactly. I have owned $ABBV for many, many years. It has always come through and since the spin off from $ABT, has been a top performer.

User Image THEGOAT83 Posted - 5 days ago

$LMDX come on Papa Roche $RHHBY & $cvs make Christmas for us special. You too $ABT sense Alere is integrated with us.

User Image OptionSamurai Posted - 5 days ago

$ABT appears in our scan that looks for calls that will explode if the stock goes to analyst target. Analysts rating is BUY and the target price is 12.1% away📈. Call 125.0, 17-Jan-25 has: Max loss of 1.1% compared to holding shares and Breakeven is 7.8% away. If the stock hits the target, the call will profit 417% 🔥🔥🔥. 👉 Create your own scan here: https://bit.ly/3lR1xIP

User Image Oldpuck Posted - 5 days ago

$ABT should be raising their dividend first week of December. That's when they usually do it

User Image MakingMeMeoutofME Posted - 5 days ago

$MDT 91 today and 95-100 year end $ABT $BSX started the rally MDT will follow into year end last 88.48

User Image Bud_Foxxx Posted - 6 days ago

$FOX $ABT $SUKU $BTC https://x.com/naiivememe/status/1855528015343861920?s=12

User Image BlueStone19 Posted - 1 week ago

$ABT looking better!

User Image iQuicky Posted - 1 week ago

$ABT back

User Image Article_AI Posted - 1 week ago

$ABT Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever You'll also like these stocks for their track record of earnings growth. https://www.stck.pro/news/ABT/92755892/

User Image Handerson171 Posted - 1 week ago

@Kingjake26 any thought about $ABT ?

User Image scottybebs Posted - 1 week ago

$ABT why down last 2 days???

User Image Article_AI Posted - 1 week ago

$ABT Abbott India posts Q2 profit rise on strong demand, price hikes Drugmaker Abbott India reported a rise in second-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications. https://www.stck.pro/news/ABT/92693965/

User Image JInvestTrade Posted - 1 week ago

$SENS $DXCM $ABT $TNDM

User Image iBoughtTheWrongTicker Posted - 1 week ago

$ABT such odd behavior for this stock

User Image ezcmezwent Posted - 1 week ago

@SecEdgarWhisperer Well…it’s a good thing I only had 3 contracts. I was completely wrong. But, I have $V and $ABT calls…and others..so, I’ll actually make out pretty well. Still not 100% sure where $DJT goes from here.

User Image TICKERTUTOR Posted - 1 week ago

$ABT When 122

User Image MakingMeMeoutofME Posted - 1 week ago

$MDT EPS Nov 19 pre mkt CEO calling for bullish 2H24 and tuck in acquisitions into 2025 growth story on 3.12 % dividend 120 targets in play for 2025 $BSX $ABT

User Image MakingMeMeoutofME Posted - 1 week ago

$MDT upgrades should be coming very soon $ABT $BSX $JNJ

Analyst Ratings
Evercore ISI Group Outperform Oct 1, 24
Jefferies Hold Sep 26, 24
Piper Sandler Overweight Sep 19, 24
Jefferies Buy Aug 27, 24
Citigroup Buy Aug 22, 24
Barclays Overweight Jul 29, 24
Evercore ISI Group Outperform Jul 2, 24
RBC Capital Outperform Jun 4, 24
Goldman Sachs Buy May 30, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Sell 112.5 42,500 4,781,250 65,027 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Jan 29 Option 52.17 42,500 2,217,225 82,527 01/31/24
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Sell 108 15,000 1,620,000 65,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 14 Option 44.4 15,000 666,000 80,027 12/18/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Sell 105.95 10,400 1,101,880 65,027 08/10/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 08 Option 38.4 5,000 192,000 75,427 08/10/23
STARKS DANIEL J Director Director Jul 27 Sell 113.72 50,000 5,686,000 6,775,316 07/28/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Sell 110.56 8,226 909,467 70,427 05/03/23
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT May 02 Option 47 8,226 386,622 78,653 05/03/23
STARKS DANIEL J Director Director Apr 28 Sell 111.36 50,000 5,568,000 6,825,316 05/02/23
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,032 103,922 52,203 03/02/23
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,092 109,964 53,656 03/02/23
Moreland Mary K EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.77 717 72,252 87,224 03/02/23
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,339 134,837 62,323 03/02/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 118,380 03/02/23
Funck, Jr. Robert E. EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,264 127,285 218,237 03/02/23
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 943 94,960 75,437 03/02/23
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,209 121,746 45,133 03/02/23
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 100.7 1,069 107,648 175,959 03/02/23
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 100.7 1,317 132,622 38,420 03/02/23
Karam Sammy SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Dec 29 Sell 108.75 4,200 456,750 26,462 01/03/23
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Dec 13 Sell 112.32 11,000 1,235,520 111,912 12/15/22
STARKS DANIEL J Director Director Oct 27 Sell 97.72 50,000 4,886,000 6,873,500 10/31/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Option 44.4 23,008 1,021,555 76,253 09/09/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Sep 08 Sell 107 23,008 2,461,856 53,245 09/09/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Option 40.13 102,425 4,110,315 244,496 08/26/22
Ford Robert B CHAIRMAN AND CEO CHAIRMAN AND CEO Aug 25 Sell 105.1 102,425 10,764,868 142,071 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Option 44.4 23,008 1,021,555 80,143 08/26/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Aug 25 Sell 105.12 26,898 2,827,518 53,245 08/26/22
STARKS DANIEL J Director Director Jul 26 Sell 109.19 50,000 5,459,500 6,923,500 07/28/22
Mateus Fernando SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 26 Sell 109.0529 2,457 267,943 14,503 07/27/22
Tyler Julie L. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Jul 25 Sell 109.09 253 27,600 33,868 07/27/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Option 44.4 24,000 1,065,600 71,854 05/05/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT May 04 Sell 113 24,000 2,712,000 47,854 05/05/22
STARKS DANIEL J Director Director May 03 Sell 113.55 50,000 5,677,500 6,973,500 05/05/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Mar 08 Sell 117.0003 4,000 468,001 41,780 03/10/22
WOODGRIFT RANDEL WILLIAM SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 964 113,848 49,223 03/02/22
Watkin Jared SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.1 1,038 122,588 66,545 03/02/22
Wainer Andrea F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.13 456 53,867 62,172 03/02/22
Salvadori Daniel Gesua Sive EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,550 183,164 112,248 03/02/22
Morrone Louis H. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.16 656 77,513 47,278 03/02/22
MANNING JOSEPH J EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 779 92,047 60,873 03/02/22
Ginascol John F EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.16 365 43,128 124,680 03/02/22
Earnhardt Lisa D EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.15 943 111,415 90,630 03/02/22
DALE MICHAEL D SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,053 124,412 45,780 03/02/22
Calamari Christopher J. SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 706 83,414 25,658 03/02/22
ALLEN HUBERT L EXECUTIVE VICE PRESI.. EXECUTIVE VICE PRESIDENT Feb 28 Sell 118.17 1,450 171,346 167,095 03/02/22
Ahlberg Gregory A SENIOR VICE PRESIDEN.. SENIOR VICE PRESIDENT Feb 28 Sell 118.15 1,099 129,847 33,274 03/02/22
McKinstry Nancy Director Director Feb 24 Option 29.84 6,280 187,395 33,419 02/25/22
McKinstry Nancy Director Director Feb 24 Sell 116.43 1,614 187,918 31,805 02/25/22